Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity: Secondary analysis of a randomised controlled trial

OBJECTIVE: To estimate the cost-consequence of treating spasticity early with botulinum toxin in the acute stroke unit. DESIGN: Secondary cost-consequence analysis, using data from a double-blind randomised-controlled trial. SETTING: Single-centre specialised stroke unit. SUBJECTS AND INTERVENTIONS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindsay, Cameron, Humphreys, Ioan, Phillips, Ceri, Pandyan, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Evaluative Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912301/
https://www.ncbi.nlm.nih.gov/pubmed/36325678
http://dx.doi.org/10.1177/02692155221133522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912301/
https://www.ncbi.nlm.nih.gov/pubmed/36325678
http://dx.doi.org/10.1177/02692155221133522

Ejemplares similares